|
 |
|
 |
Jacob Berlin, Ph.D., City of Hope
Title of Project: Stem Cell-Mediated Targeted Therapy for Triple Negative Breast Cancer |
|
|
 |
Rolf A. Brekken, Ph.D., UT Southwestern Medical Center, Dallas
Title of Project: ALK as a driver of breast cancer metastasis |
|
|
 |
Alfred I.J. Bothwell, Ph.D., Yale University
Title of Project: Modeling of Human Immune System Interaction with Breast Tumors and Treatments in Mice |
|
|
 |
Eric C. Chang, Ph.D., Baylor College of Medicine
Title of Project: N-Ras as a key regulator and potential treatment target for basal-like breast cancer |
|
|
 |
Gerald R. Crabtree, Ph.D., Stanford University
Title of Project: Targeting Ovarian Cancer via Cooperative Oncogene Interactions |
|
|
 |
Paloma H. Giangrande, Ph.D., University of Iowa
Title of Project: Multifunctional RNA-based Reagents for the Treatment of Ovarian Cancer |
|
|
 |
Andrew K. Godwin, Ph.D., University of Kansas Medical Center
Title of Project: High-Throughput Microfluidic Exosome Profiling Platform for Early Detection of Ovarian Cancer |
|
|
 |
William Hahn, Ph.D., Dana-Farber Cancer Institute, Harvard
Title of Project: Genomic Characterization of Brain Metastases from Breast Cancer |
|
|
 |
David Sherr, Ph.D., Boston University Medical Center
Title of Project: A Novel AhR-Targeted Therapeutic for Triple Negative and Chemo-Resistant Breast Cancers |
|
|
 |
Barry Sleckman, Ph.D., Washington University School of Medicine
Title of Project: Identification of Novel DNA double strand break repair targeting therapeutics for the treatment of breast cancer |
|
|
 |
LuZhe Sun, Ph.D., UT Health Science Center at San Antonio
Title of Project: Bisphenol A and Breast Cancer – Effect on Mammary Stem Cell and its Niche |
|
|
 |
John J. Turchi, Ph.D., Indiana University
Title of Project: Rational, biology-based combination therapy for the treatment of ovarian cancer |
|
|
 |
Deric Wheeler, Ph.D., Wisconsin Institute for Medical Research
Title of Project: Targeting Nuclear EGFR: Strategies for improving cetuximab therapy in triple-negative breast cancer |
|
|